Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,674 | 296 | 98.4% |
| Education | $74.99 | 1 | 1.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,107 | 71 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $842.56 | 54 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $593.10 | 45 | $0 (2024) |
| Janssen Biotech, Inc. | $510.22 | 31 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $301.14 | 15 | $0 (2024) |
| GENZYME CORPORATION | $293.04 | 13 | $0 (2024) |
| Ferring Pharmaceuticals Inc. | $194.85 | 10 | $0 (2024) |
| IRONWOOD PHARMACEUTICALS, INC | $153.00 | 11 | $0 (2024) |
| Ardelyx, Inc. | $133.10 | 7 | $0 (2024) |
| Braintree Laboratories, Inc. | $120.68 | 8 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,870 | 103 | ABBVIE INC. ($400.06) |
| 2023 | $860.65 | 50 | Takeda Pharmaceuticals U.S.A., Inc. ($168.31) |
| 2022 | $1,195 | 84 | ABBVIE INC. ($326.96) |
| 2021 | $823.25 | 60 | Takeda Pharmaceuticals U.S.A., Inc. ($252.64) |
All Payment Transactions
297 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.51 | General |
| Category: Gastroenterology | ||||||
| 12/18/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.56 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/11/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $17.62 | General |
| Category: IMMUNOLOGY | ||||||
| 12/10/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $15.86 | General |
| Category: GI | ||||||
| 12/04/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $14.35 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/02/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $22.04 | General |
| Category: Immunology | ||||||
| 11/27/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.11 | General |
| Category: Gastroenterology | ||||||
| 11/26/2024 | Ferring Pharmaceuticals Inc. | REBYOTA (Biological) | Food and Beverage | In-kind items and services | $19.24 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/25/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Education | In-kind items and services | $74.99 | General |
| Category: Immunology | ||||||
| 11/24/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $12.97 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/20/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.13 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.81 | General |
| Category: Gastroenterology | ||||||
| 11/18/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $11.55 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/13/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $19.76 | General |
| Category: IMMUNOLOGY | ||||||
| 11/12/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $16.11 | General |
| Category: GI | ||||||
| 11/06/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $19.12 | General |
| Category: Gastroenterology | ||||||
| 11/05/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $17.44 | General |
| Category: Immunology | ||||||
| 10/31/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $19.71 | General |
| Category: Gastroenterology | ||||||
| 10/31/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $1.27 | General |
| Category: Gastroenterology | ||||||
| 10/28/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $23.46 | General |
| Category: Gastroenterology | ||||||
| 10/24/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $12.08 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/16/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $23.38 | General |
| Category: IMMUNOLOGY | ||||||
| 10/15/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $20.79 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/09/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $19.39 | General |
| Category: Immunology | ||||||
| 10/08/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $17.35 | General |
| Category: INTERNAL MEDICINE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 274 | 320 | $62,802 | $22,644 |
| 2022 | 5 | 421 | 549 | $94,667 | $35,827 |
| 2021 | 7 | 616 | 798 | $124,488 | $49,086 |
| 2020 | 7 | 570 | 685 | $93,190 | $34,729 |
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 130 | 160 | $30,400 | $10,401 | 34.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 60 | 70 | $18,620 | $7,638 | 41.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 70 | 76 | $10,184 | $3,309 | 32.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 14 | 14 | $3,598 | $1,297 | 36.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 206 | 291 | $55,290 | $21,554 | 39.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 156 | 198 | $26,532 | $9,709 | 36.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 24 | 25 | $6,650 | $2,854 | 42.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 19 | 19 | $4,883 | $1,374 | 28.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 16 | 16 | $1,312 | $336.61 | 25.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 256 | 367 | $48,342 | $19,326 | 40.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 191 | 259 | $48,135 | $19,175 | 39.8% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 50 | 50 | $12,850 | $4,599 | 35.8% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 37 | 37 | $6,179 | $2,128 | 34.4% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 58 | 60 | $4,875 | $2,081 | 42.7% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 12 | 12 | $3,149 | $1,398 | 44.4% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2021 | 12 | 13 | $958.00 | $379.40 | 39.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 248 | 330 | $36,982 | $14,002 | 37.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 157 | 181 | $29,940 | $11,018 | 36.8% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 66 | 66 | $16,962 | $5,993 | 35.3% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 59 | 59 | $3,953 | $1,563 | 39.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 14 | 22 | $2,486 | $1,065 | 42.8% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 14 | 14 | $2,338 | $764.65 | 32.7% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2020 | 12 | 13 | $529.00 | $324.39 | 61.3% |
About Heidi Stertzel, PA-C
Heidi Stertzel, PA-C is a Physician Assistant healthcare provider based in Pottsville, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/02/2018. The National Provider Identifier (NPI) number assigned to this provider is 1831606748.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Heidi Stertzel, PA-C has received a total of $4,749 in payments from pharmaceutical and medical device companies, with $1,870 received in 2024. These payments were reported across 297 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($4,674).
As a Medicare-enrolled provider, Stertzel has provided services to 1,881 Medicare beneficiaries, totaling 2,352 services with total Medicare billing of $142,287. Data is available for 4 years (2020–2023), covering 23 distinct procedure/service records.
Practice Information
- Specialty Physician Assistant
- Other Specialties Medical
- Location Pottsville, PA
- Active Since 01/02/2018
- Last Updated 01/13/2026
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1831606748
Products in Payments
- DUPIXENT (Biological) $594.18
- XIFAXAN (Drug) $593.10
- ENTYVIO (Biological) $568.15
- STELARA (Biological) $329.17
- RINVOQ (Biological) $273.36
- LINZESS (Drug) $255.47
- SKYRIZI (Biological) $226.38
- ZENPEP (Drug) $157.54
- Linzess (Drug) $153.00
- IBSRELA (Drug) $133.10
- REMICADE (Biological) $122.18
- HUMIRA (Biological) $120.31
- CIMZIA (Drug) $114.74
- GATTEX (Drug) $112.24
- CREON (Drug) $101.08
- MOTEGRITY (Drug) $90.01
- DIFICID (Drug) $86.26
- SUTAB (Drug) $84.67
- REBYOTA (Biological) $80.11
- XELJANZ (Drug) $77.63
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Pottsville
Mrs. Krystle Kane, Mspa-C, MSPA-C
Physician Assistant — Payments: $4,234
Jennifer Thomas, Pa, PA
Physician Assistant — Payments: $1,586
Mrs. Amanda Johnson, Pa-C, PA-C
Physician Assistant — Payments: $1,307
Kaitlyn Strausser, Pa-C, PA-C
Physician Assistant — Payments: $1,290
Gabrielle Maxwell, Pa-C, PA-C
Physician Assistant — Payments: $593.02
Debra Olcsvay, Pa-C, PA-C
Physician Assistant — Payments: $256.23